Anaphase-Promoting Complex Adaptor FZR1/CDH1 Blocks BRAF Signaling Both by Targeting BRAF for Proteolytic Degradation
1Plexxikon Inc., Berkeley, California.
Abstract:
Blocking dimerization and stimulating protein degradation are two mechanisms known to inhibit BRAF activity. The study reported by Wan and colleagues identifies BRAF as a substrate of the APC/CFZR1-ubiqutin-proteasome system. The interaction between FZR1 and BRAF also induces a conformational change that disrupts BRAF dimerization. These findings identify a dynamic interplay between FZR1 and BRAF with strong implications for cell-fate determination and the tumor suppressor role of FZR1. Cancer Discov; 7(4); 356-8. ©2017 AACRSee related article by Wan et al., p. 424.
Insights
Researchers found that FZR1 targets BRAF for degradation, a novel mechanism that also disrupts BRAF dimerization. This discovery has significant implications for understanding cell fate and FZR1's tumor suppressor functions.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- BRAF kinase activity is regulated by protein dimerization and degradation.
- The anaphase-promoting complex/cyclosome (APC/C) is a key regulator of cell cycle progression.
- FZR1 (also known as CDH1) is a cofactor for the APC/C.
Purpose of the Study:
- To investigate the role of the APC/CFZR1 system in regulating BRAF activity.
- To identify novel mechanisms controlling BRAF protein levels and function.
Main Methods:
- Ubiquitination assays
- Co-immunoprecipitation
- Western blotting
- Cell-based assays to assess BRAF activity and dimerization
Main Results:
- BRAF is identified as a substrate of the APC/CFZR1-ubiquitin-proteasome system.
- FZR1 binds to BRAF, inducing a conformational change that inhibits BRAF dimerization.
- APC/CFZR1-mediated BRAF degradation is demonstrated.
Conclusions:
- The APC/CFZR1 complex directly regulates BRAF activity through protein degradation and disruption of dimerization.
- This interaction highlights a novel regulatory pathway for BRAF with implications for cancer development.
- FZR1's role as a tumor suppressor is further elucidated through its control of BRAF signaling.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex
DNA Damage Can Stall the Cell Cycle
MAPK Signaling Cascades
